Bioclinical Research Solutions Bel Air, MD - 21014

Bioclinical Research Solutions is categorized under Biological Research in Bel Air, MD and active since 2005.

Bioclinical Research Solutions was established in 2005, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact James Wilkinson at the company’s single location by writing to 305 Sparta Court, Bel Air, Maryland MD 21014 or by phoning (410) 836-8675. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bioclinical Research Solutions
Contact Person: James Wilkinson
Address: 305 Sparta Court, Bel Air, Maryland 21014
Phone Number: (410) 836-8675
Website Address: bioclinicalresearch.com
Annual Revenue (USD): $50.000 to $99.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Bioclinical Research Solutions was started in 2005 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact James Wilkinson for inquiries that concern Bioclinical Research Solutions by calling the company number (410) 836-8675, as your correspondence is most welcome. Additionally, the physical location of the single location of Bioclinical Research Solutions can be found at the coordinates 39.551549,-76.319879 as well as the street address 305 Sparta Court in Bel Air, Maryland 21014.

For its online presence, you may visit Bioclinical Research Solutions’s website at bioclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.